KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Tenet Healthcare (THC) Receivables - Other (2016 - 2025)

Tenet Healthcare's Receivables - Other history spans 13 years, with the latest figure at $224.0 million for Q4 2025.

  • For Q4 2025, Receivables - Other fell 2.18% year-over-year to $224.0 million; the TTM value through Dec 2025 reached $224.0 million, down 2.18%, while the annual FY2025 figure was $224.0 million, 2.18% down from the prior year.
  • Receivables - Other for Q4 2025 was $224.0 million at Tenet Healthcare, down from $282.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $282.0 million in Q3 2025 and bottomed at $15.0 million in Q2 2022.
  • The 5-year median for Receivables - Other is $193.5 million (2024), against an average of $194.8 million.
  • The largest annual shift saw Receivables - Other skyrocketed 2471.43% in 2021 before it crashed 91.18% in 2022.
  • A 5-year view of Receivables - Other shows it stood at $199.0 million in 2021, then rose by 0.5% to $200.0 million in 2022, then grew by 4.0% to $208.0 million in 2023, then increased by 10.1% to $229.0 million in 2024, then fell by 2.18% to $224.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Receivables - Other are $224.0 million (Q4 2025), $282.0 million (Q3 2025), and $264.0 million (Q2 2025).